Learn more about Genomic Health's diagnostic tests for breast, colon and prostate cancer, which can help patients and their doctor make better, more informed treatment decisions.
The Oncotype DX prostate cancer test is a genomic test that provides a precise and individualized risk assessment that a patient and his doctor can use to confidently choose the most appropriate treatment option. Learn More+
Over treatment of prostate cancer is one of the biggest issues in men’s health today. Quick and critical prostate cancer facts you and your loved ones need to know.
Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the Am...
Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ducta...
All press releases
